Stocktwits74d agobullish
CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B AcquisitionThe deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing price on Monday.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
54last 24h
976last 7d
109● bullish (7d)
121● bearish (7d)
212publishers
Investing.com74d agobullish
Crinetics soars on $10B acquisition by VertexInvesting.com -- Vertex Pharmaceuticals Incorporated announced Monday it will acquire Crinetics Pharmaceuticals, Inc. for $85.00 per share in cash, representing a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired.